HBV mRNA vaccine
2022-1371
Phase 1 mab active
Quick answer
HBV mRNA vaccine for Liver Cancer is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Liver Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active